Signaling Pathways in Cancer Pathogenesis and Therapy (Hardcover, 2012)

In recent years, increasing evidence has suggested that abnormal activation of signaling pathways is a critical event in cancer pathogenesis. In particular, activation of these pathways can lead to inappropriate cellular survival, proliferation, pluripotency, invasion, metastasis, and angiogenesis. Thus, understanding the mechanisms by which signaling pathways become subverted in a cancer cell can provide insight into critical events in cancer pathogenesis. Furthermore, as our ability to target specific molecular interactions advances, we now have the ability to design small molecules, protein therapeutics, and other forms of targeted therapies. By focusing on the specific molecular abnormalities in a cancer cell, these agents hold the potential to be much more effective and much less toxic than current cytotoxic therapies.

General

Imprint:	Springer-Verlag New York
Country of origin:	United States
Release date:	November 2011
First published:	2012
Editors:	David A Frank
Dimensions:	235 x 155 x 15mm (L x W x T)
Format:	Hardcover
Pages:	148
Edition:	2012
ISBN-13:	978-1-4614-1215-1
Categories:	Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN:	1-4614-1215-3
Barcode:	9781461412151

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!